EQUITY (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF STOCK WARRANTS OUTSTANDING TO PURCHASE COMMON STOCK

As of September 30, 2024, the Company had the following outstanding warrants to purchase common stock:

			Exercise Price		Number of
	Issuance	Expiration	Per Share		Underlying
Warrant	Date	Date	($)		Common Stocks
March 2021 Warrants	March 29, 2021	March 31, 2026		10.35		2,469,156
March 2023 Warrants	March 27, 2023	March 26, 2026		5.50		3,294,117
						5,763,273

As of December 31, 2023, the Company had the following outstanding warrants to purchase common stock:

						Number of
						Shares of
				Exercise Price		common stock
	Issuance	Expiration		Per Share		Underlying
Warrant	Date	Date		($)		Warrants
March 2021 Warrant	March 29, 2021		March 31, 2026		10.35		2,469,156
March 2023 Warrant	March 27, 2023		March 26, 2026		5.50		3,294,117
							5,763,273

SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes stock option activity for the nine months ended September 30, 2024:

	For the
	Nine months ended
	September 30, 2024
				Weighted
				average
	Number of			exercise
	Options			price
					$
Outstanding at beginning of period		2,455,069			3.46
Granted		760,500			4.76
Forfeited		(23,335	)		3
Outstanding at end of period		3,192,234			3.77
Vested at end of period		1,573,336			3.47

The following summarizes stock option activity:

	Amount of options			Weighted average exercise price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value (in thousands)
				$				$ in thousands
Outstanding - January 1, 2022		1,253,554			3.31		5.65		5,884
Granted		479,000			4.50		-		-
Forfeited		(172,514	)		3.57		-		-
Outstanding - December 31, 2022		1,560,040			3.64		5.17		2,116
Granted		986,000			3.15		-		-
Forfeited		(90,971	)		3.28		-		-
Outstanding - December 31, 2023		2,455,069			3.46		5.04		312
Options Exercisable - December 31, 2023		1,163,201			3.39		3.57		268

SCHEDULE OF STOCK-BASED PAYMENT EXPENSE

The following table sets forth the total stock-based payment expenses resulting from options and RSUs granted, included in the statements of operation and comprehensive income:

	Nine months ended September 30,				Three months ended September 30,
	2024		2023		2024		2023
	Unaudited
	USD in thousands
Cost of revenues		23		11		6		6
Research and development		402		323		177		58
Sales and marketing expenses		151		83		56		21
General and administrative		924		639		298		286
Total expenses		1,500		1,056		537		371

The following table sets forth the total stock-based payment expenses resulting from options and RSU granted, included in the statements of operation and comprehensive income:

	Year ended on December 31,
	2023		2022
	USD in thousands
Cost of revenues		22		29
Research and development		522		576
Sales and marketing expenses		126		130
General and administrative		994		903
Total expenses		1,664		1,638

SCHEDULE OF FAIR VALUE OF OPTIONS ESTIMATED ASSUMPTIONS

The fair value of each option was estimated as of the date of grant or reporting period using the Black-Scholes option-pricing model, using the following assumptions:

	Nine months ended
	September 30, 2024
Underlying value of ordinary shares ($)		5.55-5.70
Exercise price ($)		4.5-4.8
Expected volatility (%)		101	%
Term of the options (years)		7
Risk-free interest rate		3.51%-4.23	%

Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes RSU activity for the nine months ended September 30, 2024:

	For the
	Nine months ended
	September 30, 2024
				Weighted Average
	Number of			Grant Date Fair Value
	RSUs			per Share
					$
Outstanding at beginning of period		39,585			4.08
Granted		-			-
Forfeited		-			-
Vested		(19,165	)		4.34
Unvested and Outstanding at end of period		20,420			3.84

The following table summarizes RSU activity for December 31, 2023:

	Amount of RSUs			Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contractual Term (years)
				$
Outstanding - December 31, 2022		50,000			6.32		6.44
Granted		25,000			3		-
Forfeited		(7,501	)		7.2
Vested		(27,914	)		6.28		-
Unvested and Outstanding - December 31, 2023		39,585			4.08		6.30